T reatment-naive masked hypertension has been defined as discordant in-office normotension (<140/<90 mm Hg) versus out-of-office hypertension (≥135/85 mm Hg) for either home blood pressure (BP) monitoring (HBPM) or ambulatory BP monitoring (ABPM) of daytime ABPM (≥135/85 mm Hg), night-time ABPM (≥120/70 mm Hg), 24-hour ABPM (≥130/80 mm Hg), or a combination of these out-of-office BP subtypes. Masked hypertension may be a precursor of sustained hypertension, remain masked hypertension for a prolonged period of time, and occasionally revert to normotension.
T reatment-naive masked hypertension has been defined as discordant in-office normotension (<140/<90 mm Hg) versus out-of-office hypertension (≥135/85 mm Hg) for either home blood pressure (BP) monitoring (HBPM) or ambulatory BP monitoring (ABPM) of daytime ABPM (≥135/85 mm Hg), night-time ABPM (≥120/70 mm Hg), 24-hour ABPM (≥130/80 mm Hg), or a combination of these out-of-office BP subtypes. Masked hypertension may be a precursor of sustained hypertension, remain masked hypertension for a prolonged period of time, and occasionally revert to normotension. 1 However, there are at least 5 other aspects of masked hypertension of clinical importance: (1) it has been considered an intermediate phenotype between sustained normotension and sustained hypertension, which most frequently arises from antecedent high-normal BP (130-139/85-89 mm Hg), less frequently from antecedent normal BP (120-129/80-84 mm Hg); and least frequently from antecedent optimal BP (<120/<80 mm Hg) 1 (note that normal and high-normal BP when combined are called prehypertension); (2) it frequently is associated with hypertensive target organ damage even without progressing to hypertension, perhaps because of increased pressure burden in daily life, and despite a long-dormant period before transitioning to sustained hypertension 1 ; (3) it has been associated with many cardiometabolic abnormalities, including obesity, metabolic syndrome, diabetes mellitus, obstructive sleep apnea, and chronic renal disease 1 ; (4) it frequently has been associated with nocturnal hypertension and impaired nocturnal dipping of BP-a particularly high-risk phenotype 2 ; and (5) there is an especially high prevalence of masked hypertension in people of African descent, approaching 30% to 50% in some series. [3] [4] [5] [6] It is with this background that the present investigators used ABPM to define masked hypertension as a possible precursor of incident clinic hypertension in 317 treatment-naive participants from the Jackson Heart Study, a prospective cohort of blacks. 7 The mean age of this group was 54.8 years, mean body mass index was 30.1 U, prevalence of diabetes mellitus was 11.7%, any masked hypertension subtype was 45.4%, and the presence of left ventricular hypertrophy was 11.1%. Incident clinic hypertension was defined as the first visit with either clinic systolic/diastolic BP ≥140/90 mm Hg or initiation of antihypertensive medication. With a median follow-up of 8.1 years, representing study visits in 2005 to 2008 and 2009 to 2012, there were 187 (59%) incident cases of clinic hypertension: 79% and 42% of participants with and without any masked hypertension, respectively. Thus, the major new finding is that individuals with any subtype of masked hypertension-daytime, night-time, or 24-hour ABPM-had twice the risk for developing incident clinic hypertension when compared with those with antecedent sustained normotension. These proportions between masked hypertension and sustained normotension were generally consistent when assessing daytime, night-time, or 24-hour ABPM; but, after multivariable-adjustment, night-time masked hypertension had a somewhat greater predictive power for incident clinic hypertension. Using any definition of masked hypertension, 51.9% of participants with prehypertension and 14.7% of those with normal clinic BP (often referred to as optimal BP in other studies), developed incident hypertension during the 8.1-year follow-up. Multivariable-adjusted hazard ratios were significant for incident clinic hypertension in any masked hypertension subtype. Finally, after stratifying individuals by prehypertension versus normal clinic BP, the association between masked hypertension and incident clinic hypertension remained significant in both groups. The authors suggested that preventive strategies, that is, lifestyle modification might be useful to prevent progression of masked hypertension to clinic hypertension not only in those with prehypertensive clinic BP but even in those with optimal clinic BP. However, if evidence of target organ damage such as left ventricular hypertrophy was present, antihypertensive treatment might be a particularly important consideration. Furthermore, this study should be interpreted within the context of its limitations.
Role of Nocturnal Hypertension
There is an evidence that nocturnal hypertension plays an important role in the development of masked hypertension, particularly in blacks. In a previous Jackson Heart Study that included 425 untreated normotensive and hypertensive individuals undergoing ABPM, masked hypertension was associated with isolated nocturnal hypertension in 19% of untreated individuals; these subjects had a greater prevalence of left ventricular hypertrophy than their normotensive counterparts in age-and sex-adjusted models. 3 In a more recent Jackson Heart Study, conducted in 972 blacks, masked hypertension was noted in 34.4% of participants with normal clinic BP.
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July 2016 treatment were predictors of masked hypertension in multivariate analysis. 4 The authors also speculated that "psychosocial stress, sleep apnea as well as biological factors such as arterial stiffness, inflammation, endothelial dysfunction, and salt sensitivity may be possible mechanisms. [39] [40] [41] [42] " Although results of this cross-sectional study do not implicate causation in the development of masked hypertension, they lend themselves to speculation about possible additional causes of masked hypertension, such as transient BP elevation from cigarette smoking, which is not done in the doctor's office, or noncompliance to medications, which patients are more likely to take before visiting their doctor.
Importantly, the recent Ambulatory Blood Pressure Collaboration study in Patients With Hypertension (ABC-H), a meta-analysis of 17 312 hypertensive patients from 3 continents, has confirmed the prognostic importance of nocturnal hypertension in both masked hypertension and sustained hypertension. 2 This meta-analysis demonstrated that a blunted nocturnal BP decline, both as a mean night-time sleep entity and as a categorical nondipping subgroup, was a predictor of worse cardiovascular outcomes, independent of average ambulatory daytime, or 24-hour BP levels. 2 In addition, reverse dippers (risers) and untreated extreme dippers had a worse prognosis than nondippers. 2 The nocturnal dipping status was not reported in this study, but may have added to the prediction of incident hypertension.
Role of HBPM
The authors listed the lack of HBPM as a limitation of the study and suggested that HBPM could be an alternative method of determining masked hypertension. It should be noted, however, that a Chinese study from the Ruijin Shanghai hospital, using HBPM, in comparison with ABPM, failed to diagnose masked and sustained hypertension in >25% of patients. 8 This study, therefore, confirmed the importance of nocturnal hypertension in establishing the total number of individuals with masked hypertension. However, a single ABPM study may not display the normal variation in BP that occurs over an extended period of time. For example, in this study, only 23.5% of masked hypertension evolved into sustained hypertension without first receiving antihypertensive treatment. Because visit 2 (2005-2008) and visit 3 (2009-2012) were separated by several years, the majority of Jackson Heart Study subjects were started on antihypertensive treatment before masked hypertension could be confirmed and most probably after BP had evolved into sustained hypertension. Indeed, if HBPM had been part of the standard protocol, an earlier diagnosis of masked hypertension may have resulted in earlier administration of treatment and possible prevention of target organ damage. Furthermore, because ABPM was not repeated after starting antihypertensive treatment, many of these patients may have been under treated. In a Spanish ABPM Registry Trial, 31% of treated hypertensive subjects failed to reach target BP because of so-called masked uncontrolled hypertension-more frequently because of night-time than daytime masked uncontrolled hypertension, and many of these patients had high-risk features (ie, males, smokers, the obese, and diabetics).
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Role of Lifestyle Intervention in Masked Hypertension
The authors advocated lifestyle intervention for masked hypertension in the absence of target organ damage, to prevent its progression to incident hypertension. Importantly, a lifetime risk study showed that primordial lifestyle intervention in young adults was more effective in preventing future cardiometabolic events than primary prevention in older adults. 10 By the same token, lifestyle intervention in this study would be more effective if begun earlier to prevent the development of masked hypertension. The major strengths of this study include both the application of ABPM to a sizeable cohort of black individuals and the novelty and potential importance of the above findings. The observational data underscore the urgent need for the first proper randomized controlled trial to address the nagging question: does medication management of masked hypertension prevent heart attacks, strokes, and other major cardiovascular and renal complications of hypertension?
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